Biodesix Inc Ordinary Shares BDSX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $27.33
- Day Range
- $26.97–28.72
- 52-Week Range
- $5.26–31.97
- Bid/Ask
- $23.00 / $29.98
- Shares Outstanding
- 10.55M
- Market Cap
- $292.48M
- Volume/Avg
- 124,341 / 98,673
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.39
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Growth
- Total Number of Employees
- 334
- Website
- https://www.biodesix.com
Valuation
|
Metric
|
BDSX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 31.98 |
Price/Sales | 2.39 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BDSX
|
|---|---|
Quick Ratio | 2.56 |
Current Ratio | 2.85 |
Interest Coverage | −2.43 |
Quick Ratio
BDSX
Profitability
|
Metric
|
BDSX
|
|---|---|
Return on Assets (Normalized) | −26.08% |
Return on Equity (Normalized) | −777.37% |
Return on Invested Capital (Normalized) | −20.69% |
Return on Assets
BDSX
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|YvG%trC | LOCK|QGc | $242B | |||
| Danaher Corp
DHR
| LOCK|J!HWPM%& | LOCK|L# | $150B | |||
| Agilent Technologies Inc
A
| LOCK|#&$X&dtH | LOCK|lXc | $47B | |||
| IQVIA Holdings Inc
IQV
| LOCK|>hdR!& | LOCK|N&NB? | $43B | |||
| Waters Corp
WAT
| LOCK|!R&qD#! | LOCK|?r | $42B | |||
| Illumina Inc
ILMN
| LOCK|jH?<j# | LOCK|&T%f | $41B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|<@>W#S#% | LOCK|<N | $41B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|$dc%^^V | LOCK|p!B< | $30B | |||
| Quest Diagnostics Inc
DGX
| LOCK|g>DkM# | LOCK|??V# | $26B | |||
| Labcorp Holdings Inc
LH
| LOCK|y<b#J@KB | LOCK|xF>H | $25B |
United States